‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.